AstraZeneca (AZN) Rejects Pfizer Offer

Shares of AstraZeneca Plc. (AZN) were off -9.27 or -11.55 percent to $71.01 per share in pre-market trading this morning, after the company rejected a

Published on May 19, 2014
By Jay Hawk
Jay Hawk
Jay Hawk enjoyed a 12-year professional financial markets career incorporating extensive first hand futures and options experience obtained by trading in the stock, commodity and forex markets on U.S. exchanges. Since retiring as a full-time financial market professional, he has been actively trading stock, commodities, forex and options for his own account and managing funds for others, as well as writing financial market commentary and educational articles.

Copyrighted 2020. Content published with author's permission.

Posted in ...